Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00558857 · ClinicalTrials.gov registry record · Phase 1
Dynamic Substrate Mapping (DSM) for Ischemic VT
A Phase 1 study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT00558857 is a Phase 1 study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 5 participants.
The verdict
NCT00558857, a Phase 1 study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized study to determine the feasibility of using a new technique called Dynamic Substrate Mapping (DSM) to help guide the treatment of ischemic ventricular tachycardia (IVT). We hypothesize that DSM will lead to simpler, more effective ablation of IVT. Results from this study will be used to determine if further clinical investigation is warranted.
Interventions
- DEVICE Dynamic Substrate Mapping-guided ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00558857
The ClinicalTrials.gov registry entry for NCT00558857 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dynamic Substrate Mapping-guided ablation is the first listed.
NCT00558857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00558857 about?
NCT00558857 is a clinical study titled "Dynamic Substrate Mapping (DSM) for Ischemic VT". This is a prospective, non-randomized study to determine the feasibility of using a new technique called Dynamic Substrate Mapping (DSM) to help guide the treatment of ischemic ventricular tachycardia (IVT). We hypothesize that DSM will lead to simpler, more effective ablation of IVT. Results from t...
What is the current status of trial NCT00558857?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2007-07. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00558857?
The interventions under investigation include: Dynamic Substrate Mapping-guided ablation (DEVICE).
Who is sponsoring clinical trial NCT00558857?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.